Effectiveness and Safety of Palbociclib: Brand vs. Generic in Iraqi Stage IV Breast Cancer Patients
ACTIVE_NOT_RECRUITING
Status
Conditions
- Brest Cancer
- CDK4/6 Inhibitor
Interventions
- DRUG: Palbociclib (Brand vs Generic) compartive
Sponsor
Al-Mustansiriyah University
Collaborators